ABOUT
A Talented, Experienced and Global Team
Executive Management
Vinod Vijayakumar
D.Phil Eng. (Oxon), CEO
20+ years early stage medical product development experience
Focus on translational development and regulatory strategy/execution
Jukka Tuominen
D.Sc. Eng., CTO
25+ yrs experience developing novel biomaterials, including for Cervidil®/ Propess; 10 patents; 40+ publications
Previously Principal Scientist at Corbion Purac responsible for science & development programs
Harri Jukarainen
M.Sc. Eng., CSO
25+ years experience in polymer-based sustained release formulation development; 30+ patents/publications
Previously Scientist at Bayer developing innovative controlled drug delivery platforms
Board of Directors
Robert Watson
D.Phil (Oxon), Board Chairman
20+ yrs experience in life sciences investment and strategy
Co-founder/Managing Partner of Gyrus Capital
Previously Managing Director at Altaris Capital Partners, Ares Life Sciences, and Sofinnova Partners
Jonathan Glen
Founder, Board Member
Chairman of PiBond Oy, semiconductor polymer manufacturer
Founder of ReneSola SOL NYSE
Chairman of Aleva Neurotherapeutics SA
Kristoffer Andenaes
Co-Founder, Board Member
Leading Scandinavian investor with focus on CleanTech and MedTech
Runs a family office in Oslo, Norway with interests in a portfolio of private and public companies
World-Class Advisors
EXPERTS FOCUSED ON THE EYE
Arto Urtti
Ph.D
Professor of Biopharmaceutics (Ophthalmic), University of Eastern Finland; Director, Centre for Drug Research, University of Helsinki
Peter Adamson
Ph.D.
Professor, Institute of Ophthalmology, University College London; Formerly VP/Head of Ophthalmology Research, GlaxoSmithKline
Hari Jayaram
MRCOphth, Ph.D
Deputy Director, Glaucoma Service; Co-Chair Research Management Committee Moorfields Eye Hospital (NHS) London
